My watch list
my.chemeurope.com  
Login  

Combivir



Combivir is the brand name for a pharmaceutical treatment for HIV infection. It is a fixed dose combination of two antiretroviral drugs, lamivudine (also called 3TC, with the brand name Epivir) and zidovudine (also called AZT, with the brand name Retrovir ). The combination of the two drugs has a stronger effect than either drug alone.

Additional recommended knowledge

Both lamivudine and zidovudine are reverse transcriptase inhibitors, which block the action of an enzyme, reverse transcriptase, that the virus requires for reproduction. It reduces the viral load in the body and raises CD4 cell count.

It was approved by the FDA on September 26, 1997, making it the thirteenth approved antiretroviral. It is marketed by GlaxoSmithKline.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Combivir". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE